Valuation: AngioDynamics, Inc.

Market Cap 636M 565M 528M 481M 906M 61.2B 918M 6.39B 2.47B 31.17B 2.39B 2.33B 100B P/E 2027 *
-29.2x
P/E 2028 * -52.4x
Enterprise Value 636M 565M 528M 481M 906M 61.2B 918M 6.39B 2.47B 31.17B 2.39B 2.33B 100B EV / Sales 2027 *
1.88x
EV / Sales 2028 * 1.79x
Free-Float
84.61%
Yield 2027 *
-
Yield 2028 * -
1 day-1.69%
1 week-1.05%
Current month-1.69%
1 month-4.67%
3 months+15.60%
6 months+26.63%
Current year+17.76%
1 week 14.89
Extreme 14.89
15.76
1 month 14.85
Extreme 14.85
16.22
Current year 9.39
Extreme 9.39
16.29
1 year 9.39
Extreme 9.39
16.29
3 years 5.26
Extreme 5.26
16.29
5 years 5.26
Extreme 5.26
32
10 years 5.26
Extreme 5.26
32
Manager TitleAgeSince
Chief Executive Officer 62 01/04/2016
Director of Finance/CFO 51 23/10/2019
Chief Tech/Sci/R&D Officer - 01/01/2017
Director TitleAgeSince
Chairman 65 29/04/2014
Director/Board Member 67 29/01/2007
Director/Board Member 62 01/04/2016
Date Insider Type Main position Quantity % Market Cap. Importance
30/7/26 Sell

General Counsel

-23,370 0.0565%
22/7/26 Exercice

Executive/Senior Manager

40,889 0.0990%
22/7/26 Exercice

General Counsel

27,417 0.0664%
Change 5-day change 1-year change 3-year change Capi.($)
-1.69%-1.05%+36.59%+103.23% 636M
-2.15%-4.31%-27.54%+1.02% 171B
+0.17%-2.34%-8.83%+11.15% 110B
-0.81%+1.26%-24.99%-0.25% 106B
-0.69%-3.57%-47.61%-12.45% 75.99B
+3.17%-0.03%-0.64%+72.98% 57.3B
-0.52%-0.65%-6.74%-30.92% 48.76B
+3.44%+7.90%+19.12%+59.15% 50.19B
-0.85%+0.85%-16.51%+20.14% 41.14B
-0.07%-1.42%+30.49%-8.80% 32.56B
Average +0.19%-1.40%-4.67%+21.53% 69.36B
Weighted average by Cap. -0.00%-2.07%-15.87%+9.64%

Financials

2027 *2028 *
Net sales 337M 300M 280M 255M 481M 32.48B 487M 3.39B 1.31B 16.54B 1.27B 1.24B 53.13B 355M 315M 295M 269M 506M 34.2B 513M 3.57B 1.38B 17.42B 1.33B 1.3B 55.94B
Net income -22.3M -19.81M -18.52M -16.88M -31.78M -2.15B -32.21M -224M -86.74M -1.09B -83.73M -81.91M -3.51B -12.67M -11.25M -10.52M -9.59M -18.05M -1.22B -18.3M -127M -49.27M -621M -47.56M -46.53M -1.99B
Net Debt - -
Logo AngioDynamics, Inc.
AngioDynamics, Inc. is a transformative medical technology company. The Company is focused on restoring healthy blood flow in the body's vascular system, expanding cancer treatment options and improving quality of life for patients. It designs, manufactures, and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Its devices are generally used in minimally invasive, image-guided procedures. Its segments include Med Tech and Med Device. The Med Tech segment is comprised of its technology portfolio including Auryon, the thrombus management platform and NanoKnife. The Med Device segment includes its Core, Venous, Ports and other Oncology products. Its product types are Ablation, Catheters, Medical Balloons, and Ports. The Catheter products include Angiographic Catheters, Uni-Fuse Infusion Catheter and Drainage Catheters.
Employees
632
Date Price Change Volume
02/10/26 USD 15.12 -1.69% 685,123
30/09/26 USD 15.38 -1.41% 634,475
29/09/26 USD 15.60 +0.39% 862,102
28/09/26 USD 15.54 +0.32% 533,567
25/09/26 USD 15.49 +1.37% 635,494
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
15.38USD
Average target price
20.00USD
Spread / Average Target
+30.04%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ANGO Stock